Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Researchers evaluating the regulatory picture around this and similar research compounds can also read our breakdown of BPC-157 FDA approval status
The numbers should be clearly visible through the dose window
Reported side effects in limited human use include mild nausea and dizziness
The results suggested that TB-500 not only potentially enhanced the viability, angiogenesis, and migratory ability of HUVEC but possibly also promoted the expression of angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), vascular endothelial growth factor A (VEGFA), NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), NF-B, and phosphorylated (p)-p65 in HUVEC
US$ 23.68
US$ 26.62
US$ 27.87
US$ 21.97
US$ 29.58
US$ 23.80
US$ 28.67
US$ 28.15
US$ 21.44
US$ 28.91
